Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Association of coronary artery disease and chronic kidney disease in Lebanese population.

Milane A, Khazen G, Zeineddine N, Amro M, Masri L, Ghassibe-Sabbagh M, Youhanna S, Salloum AK, Haber M, Platt DE, Cazier JB, Othman R, Kabbani S, Sbeite H, Chami Y, Chammas E, El Bayeh H, Gauguier D, Abchee AB, Zalloua P, Barbari A.

Int J Clin Exp Med. 2015 Sep 15;8(9):15866-77. eCollection 2015.

2.

Risk of pneumonia among patients with chronic kidney disease in outpatient and inpatient settings: a nationwide population-based study.

Chou CY, Wang SM, Liang CC, Chang CT, Liu JH, Wang IK, Hsiao LC, Muo CH, Huang CC, Wang RY.

Medicine (Baltimore). 2014 Dec;93(27):e174. doi: 10.1097/MD.0000000000000174.

3.

Blastocystis and schistosomiasis coinfection in a patient with chronic kidney disease.

Young CR, Yeo FE.

Case Rep Med. 2014;2014:676395. doi: 10.1155/2014/676395. Epub 2014 Oct 19.

4.

T-cell ageing in end-stage renal disease patients: Assessment and clinical relevance.

Meijers RW, Betjes MG, Baan CC, Litjens NH.

World J Nephrol. 2014 Nov 6;3(4):268-76. doi: 10.5527/wjn.v3.i4.268. Review.

5.

Vitamin D and the Immune System from the Nephrologist's Viewpoint.

Lang CL, Wang MH, Chiang CK, Lu KC.

ISRN Endocrinol. 2014 Jan 22;2014:105456. doi: 10.1155/2014/105456. eCollection 2014. Review.

6.

Leukocyte proliferation and immune modulator production in patients with chronic kidney disease.

Mansouri L, Paulsson JM, Moshfegh A, Jacobson SH, Lundahl J.

PLoS One. 2013 Aug 9;8(8):e73141. doi: 10.1371/journal.pone.0073141. eCollection 2013.

7.

Elevated pretransplantation soluble BAFF is associated with an increased risk of acute antibody-mediated rejection.

Banham G, Prezzi D, Harford S, Taylor CJ, Hamer R, Higgins R, Bradley JA, Clatworthy MR.

Transplantation. 2013 Aug 27;96(4):413-20. doi: 10.1097/TP.0b013e318298dd65.

8.

Altered molecular repertoire of immune system by renal dysfunction in the elderly: is prediction and targeted prevention in the horizon?

Lang CL, Wang MH, Hung KY, Chiang CK, Lu KC.

EPMA J. 2013 Jun 21;4(1):17. doi: 10.1186/1878-5085-4-17. eCollection 2013.

9.

Immune dysfunction in uremia—an update.

Cohen G, Hörl WH.

Toxins (Basel). 2012 Oct 24;4(11):962-90. doi: 10.3390/toxins4110962. Review.

10.

B cell-associated immune profiles in patients with end-stage renal disease (ESRD).

Kim KW, Chung BH, Jeon EJ, Kim BM, Choi BS, Park CW, Kim YS, Cho SG, Cho ML, Yang CW.

Exp Mol Med. 2012 Aug 31;44(8):465-72. doi: 10.3858/emm.2012.44.8.053.

11.

Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment.

McGrath LJ, Kshirsagar AV, Cole SR, Wang L, Weber DJ, Stürmer T, Brookhart MA.

Arch Intern Med. 2012 Apr 9;172(7):548-54. doi: 10.1001/archinternmed.2011.2238.

12.

Effect of uremia on structure and function of immune system.

Vaziri ND, Pahl MV, Crum A, Norris K.

J Ren Nutr. 2012 Jan;22(1):149-56. doi: 10.1053/j.jrn.2011.10.020. Review.

13.
14.

Different profiles of cytokine expression during mild and severe acute pancreatitis.

Dambrauskas Z, Giese N, Gulbinas A, Giese T, Berberat PO, Pundzius J, Barauskas G, Friess H.

World J Gastroenterol. 2010 Apr 21;16(15):1845-53.

15.

Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression.

Pahl MV, Gollapudi S, Sepassi L, Gollapudi P, Elahimehr R, Vaziri ND.

Nephrol Dial Transplant. 2010 Jan;25(1):205-12. doi: 10.1093/ndt/gfp397. Epub 2009 Aug 14.

16.

Aspects of immune dysfunction in end-stage renal disease.

Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1526-33. doi: 10.2215/CJN.00950208. Epub 2008 Aug 13. Review.

17.

Alteration of peripheral blood lymphocyte subsets in acute pancreatitis.

Pietruczuk M, Dabrowska MI, Wereszczynska-Siemiatkowska U, Dabrowski A.

World J Gastroenterol. 2006 Sep 7;12(33):5344-51.

Supplemental Content

Support Center